CPHCF-2023-023/the Cutting-edge Cancer Support Treatment Research Project[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Systemic immune-inflammation index as a prognostic marker in HER2-positive breast cancer patients undergoing trastuzumab therapy.

Pang J, Ding N, Yin N, Xiao Z. Pang J, et al. Sci Rep. 2024 Mar 19;14(1):6578. doi: 10.1038/s41598-024-57343-0. Sci Rep. 2024. PMID: 38503890 Free PMC article.

Prognostic Value of the Baseline Systemic Immune-Inflammation Index in HER2-Positive Metastatic Breast Cancer: Exploratory Analysis of Two Prospective Trials.

Pang J, Ding N, Liu X, He X, Zhou W, Xie H, Feng J, Li Y, He Y, Wang S, Xiao Z. Pang J, et al. Ann Surg Oncol. 2024 Nov 20. doi: 10.1245/s10434-024-16454-8. Online ahead of print. Ann Surg Oncol. 2024. PMID: 39565489

ASO Author Reflections: Reflections on the Role of the Systemic Immune-Inflammation Index in Prognostic Assessment in HER2-Positive Metastatic Breast Cancer.

Pang J, Ding N, Liu X, He X, Zhou W, Xie H, Feng J, Li Y, He Y, Wang S, Xiao Z. Pang J, et al. Ann Surg Oncol. 2024 Dec 10. doi: 10.1245/s10434-024-16664-0. Online ahead of print. Ann Surg Oncol. 2024. PMID: 39656393 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters